Eiko LifeSciences Limited (BOM:540204)
53.31
+0.28 (0.53%)
At close: May 27, 2026
Eiko LifeSciences Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 136.14 | 117.81 | 133.46 | 6.12 | 2.17 |
Cash & Short-Term Investments | 136.14 | 117.81 | 133.46 | 6.12 | 2.17 |
Cash Growth | 15.57% | -11.73% | 2079.30% | 181.82% | -96.68% |
Accounts Receivable | 202.18 | 107.86 | 131.34 | 71.06 | 45.62 |
Receivables | 202.18 | 107.86 | 131.34 | 71.06 | 45.62 |
Inventory | 39.72 | 57.75 | 33.86 | 9.08 | 54.58 |
Prepaid Expenses | - | - | 0.06 | 0.6 | 0.19 |
Other Current Assets | 96.03 | 45.36 | 10.57 | 6.16 | 31.95 |
Total Current Assets | 474.07 | 328.77 | 309.29 | 93.01 | 134.51 |
Property, Plant & Equipment | 221.03 | 231.19 | 135.65 | 138.81 | 142.89 |
Long-Term Investments | 152.94 | 71.54 | 40.18 | 11.76 | 58.67 |
Other Long-Term Assets | 0 | 29.51 | 41.42 | 43.7 | - |
Total Assets | 893.7 | 661.01 | 527.39 | 310.43 | 348.94 |
Accounts Payable | 125.6 | 33.15 | 13.81 | 10.45 | 13.49 |
Accrued Expenses | - | 3.13 | 0.33 | 0.86 | 0.65 |
Short-Term Debt | 16.75 | 7.55 | - | - | 45 |
Current Portion of Long-Term Debt | - | - | - | 0.54 | 0.75 |
Current Income Taxes Payable | 3.3 | 2.36 | 0.64 | - | - |
Other Current Liabilities | 8.16 | 16.47 | 0.27 | 0.14 | 0.18 |
Total Current Liabilities | 153.79 | 62.65 | 15.05 | 11.99 | 60.06 |
Long-Term Debt | 30.56 | 20.08 | - | - | 0.54 |
Long-Term Deferred Tax Liabilities | 11.1 | 8.21 | 5.56 | 4.22 | 2.05 |
Other Long-Term Liabilities | - | 0 | - | - | -0 |
Total Liabilities | 195.45 | 90.95 | 20.61 | 16.21 | 62.64 |
Common Stock | 143.46 | 137.63 | 128.73 | 83.16 | 83.16 |
Additional Paid-In Capital | - | 375.2 | 344.06 | 184.58 | 184.58 |
Retained Earnings | - | 55.06 | 34 | 26.48 | 18.56 |
Comprehensive Income & Other | 544.33 | -0 | - | - | - |
Total Common Equity | 687.79 | 567.89 | 506.78 | 294.22 | 286.3 |
Minority Interest | 10.46 | 2.18 | - | - | - |
Shareholders' Equity | 698.25 | 570.06 | 506.78 | 294.22 | 286.3 |
Total Liabilities & Equity | 893.7 | 661.01 | 527.39 | 310.43 | 348.94 |
Total Debt | 47.3 | 27.63 | - | 0.54 | 46.28 |
Net Cash (Debt) | 88.84 | 90.17 | 133.46 | 5.59 | -44.1 |
Net Cash Growth | -1.48% | -32.44% | 2288.33% | - | - |
Net Cash Per Share | 6.30 | 6.92 | 12.94 | 0.57 | -5.65 |
Filing Date Shares Outstanding | 13.98 | 13.86 | 13.86 | 8.32 | 8.32 |
Total Common Shares Outstanding | 13.98 | 13.86 | 13.86 | 8.32 | 8.32 |
Working Capital | 320.28 | 266.11 | 294.24 | 81.03 | 74.45 |
Book Value Per Share | 49.20 | 40.97 | 36.56 | 35.38 | 34.43 |
Tangible Book Value | 687.79 | 567.89 | 506.78 | 294.22 | 286.3 |
Tangible Book Value Per Share | 49.20 | 40.97 | 36.56 | 35.38 | 34.43 |
Buildings | - | 53.41 | 38.57 | 38.29 | 38.11 |
Machinery | - | 87.85 | 89.7 | 87.28 | 85.2 |
Leasehold Improvements | - | 28.63 | 28.63 | 27.88 | 27.88 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.